Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Actera Pharmaceuticals

Actera Pharmaceuticals
Out of Business LATEST DEAL TYPE

Operator of a biotechnology company intended to develop medicines. The company's biotechnology service formulates fixed-dose combination products and other drug products with physical, chemical or biopharmaceutical constraints, enabling doctors to treat diseases.

Ownership Status
Out of Business
Financing Status
Formerly Accelerator/Incubator backed
Primary Industry
Other Industries
Other Pharmaceuticals and Biotechnology
Primary Office
  • 953 Indiana Street
  • QB3@953 Mail Stop 51
  • San Francisco, CA 94107
  • United States
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Actera Pharmaceuticals’s full profile, request a free trial.

Actera Pharmaceuticals Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Out of Business 01-May-2016 Completed Out of Business
1. Accelerator/Incubator Completed Startup
To view this company’s complete deal history including valuation and funding, request access »

Actera Pharmaceuticals Executive Team (2)

Name Title Board
Mark Menning Ph.D Co-Founder & Managing Director
Sean Dalziel Ph.D Co-Founder & Managing Director